A Long-Term Extension Study to Evaluate the Safety and Efficacy of Ritlecitinib in Participants With Severe AA Who Have Completed Studies B7981027 or B7981031

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 93c14df9d80daf21cb9b8b8af4df77c95d2c9e40
First added on: Jan 17, 2026